Cortlandt Forum Exclusives

Exposure to moisture leads to palmar rash

Caroline Y. Winslow and Julia R. Nunley, MD September 02, 2010

A 24-year-old woman presented with a six-year history of a recurring, somewhat painful and pruritic palmar rash that developed on either hand within minutes of exposure to water.
 

Collis-Nissen fundoplication for a symptomatic paraesophageal hernia

Ashley L. Racette, PA-C, MPAS; Richard T. Miller, MD September 02, 2010

A laparoscopic approach leads to relief of the patient's gastroesophageal reflux, uneventful surgery, and a smooth recovery
 

Tender, edematous, red plaques on a woman's hands and feet

Jennifer Stead, DO, and Stuart Gildenberg, MD August 25, 2010

One month after starting a new chemotherapeutic drug, the patient sought treatment for painful peeling and redness on her hands and feet.
 

Making the best use of osteoporosis agents

Jack Waxman, MD August 19, 2010

There are changes in the wind for patients with osteoporosis and their clinicians. But don't underestimate currently available therapies.
 

HPV cotest affects cervical cancer screening

August 10, 2010

Clinicians are likely to test the patient more frequently when using Pap and human papillomavirus (HPV) tests together, a survey shows.
 

Daily Medical News




Anticoagulation therapy in cancer patients

Question asked by Edgar C. Salire, NP-C, Pearland, Tex., and answered by Debra Kleinschmidt, PhD, PA

At what platelet count can I safely initiate long-term anticoagulation with warfarin (Coumadin) in cancer patients with thrombocytopenia and persistent atrial fibrillation?
 

Lymphedema treatment options

Question asked by Paula Jauering, ARNP, and answered by Philip R. Cohen, MD

Chronic lymphedema often turns into cellulitis in patients with diabetes. What is the preferred...
 

Who should be screened for celiac disease?

Question asked by Nathan W. Keever, DO, Cazenovia, N.Y., and answered by Laura G. Kehoe, MD

I am seeing celiac disease diagnosed more frequently. I suspect this is because the antigliadin serology is available, but I worry that this is going to become an...
 

How long can a patient with GERD take a PPI?

Is there a limit to how long a patient with gastroesophageal reflux disease symptoms can be treated with a proton pump inhibitor?
 

Take a new look
at our cartoons


From the very first, Cortlandt Forum has been bringing you the best in cartoons. Now that we're exclusively online, we figured we'd make it easier for you to flip through our collection. Click here to take a quick look at our newest 'toons.


"I don't think I've seen your brother, what does he look like?"

And keep coming back—we're always adding to our library!

Sign up for our newsletters

Register now to receive Cortlandt Forum's newsletters. Each week we'll give you something new: Derm Xtra highlights our premier dermatology content; Pulse gives you the latest rundown of what's on our Web site; mid-month, we Spotlight a condition common to your practice; and we round out the month on The Lighter Side—geared to provide you with a few chuckles amidst the ups and downs of clinical practice.

Alternative Meds Index


 
Visit the Alternative Meds Index, brought to you by our sister publication The Clinical Advisor, for the latest on butterbur and other treatments.

Take Cortlandt Forum
with you anywhere!

We're mobile! Get instant access to the latest news, case reports, and features from Cortlandt Forum. Simply type www.cortlandtforum.com into any mobile device. We're with you wherever you go!

MPR Drug News

Abbott RealTime HBV test approved

September 02, 2010

Abbott announced that the FDA has approved its RealTime HBV assay for measuring the amount of hepatitis B virus (HBV) in human plasma or serum from individuals chronically infected with HBV.
 

Tygacil labeling updated to include increased mortality risk

September 01, 2010

The FDA is reminding healthcare professionals that intravenous Tygacil (tigecycline, from Pfizer) can increase mortality risk in the treatment of serious bacterial infections.
 

Suboxone sublingual film approved to treat opioid dependence

August 31, 2010

Reckitt Benckiser announced that the FDA has approved Suboxone (buprenorphine and naloxone) sublingual film for maintenance treatment of opioid dependence in conjunction with counseling and psychosocial support.
 

Give us a piece of your mind!

Disagree with something in one of our articles, or have a question for the author? Post your comments on the Cortlandt Forum Web site in the box at the bottom of any article. And see what your colleagues are saying by browsing their comments.

Conference Coverage


 Subscribe to the RSS for this page  [view all our RSS feeds here]